Characterization of upper airway microbiome across severity of COVID-19 during hospitalization and treatment
Description
Longitudinal studies on upper respiratory tract microbiome in coronavirus disease 2019 (COVID-19) without potential confounders such as antimicrobial therapy are limited. The objective of this study is to assess for longitudinal changes in the upper
